Hairy Cell Leukemia: Strategies for Improved Patient Outcomes
Failed to add items
Sorry, we are unable to add the item because your shopping cart is already at capacity.
Add to Cart failed.
Please try again later
Add to Wish List failed.
Please try again later
Remove from wishlist failed.
Please try again later
Adding to library failed
Please try again
Follow podcast failed
Please try again
Unfollow podcast failed
Please try again
Hairy Cell Leukemia: Strategies for Improved Patient Outcomes
-
Narrated by:
-
By:
Paul J. Hampel, MD, Mayo Clinic, Rochester, MN
Recorded on November 4, 2025
Paul J. Hampel, MD
Assistant Professor of Medicine
Division of Hematology, Department of Medicine
Mayo Clinic
Rochester, MN
In this episode, Dr. Paul Hampel from Mayo Clinic Rochester takes a comprehensive look at hairy cell leukemia (HCL). He reviews the current diagnostic work-up, including immunophenotypic and molecular testing, and highlights key clinical features that distinguish HCL from related disorders. Dr. Hampel also discusses approved frontline therapies and evidence-based approaches for relapsed or refractory disease, with attention to infection risk and supportive care. The conversation explores emerging agents, novel combinations, and clinical trials shaping the next wave of HCL management. Join us for this expert discussion, offering practical insights to enhance care and outcomes for patients with HCL.
No reviews yet